Nery Sanchez

Managua, MN, Nicaragua

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications

Hemagglutination inhibition and alternate serologic responses following Influenza A(H3N2) virus infection.

Hemagglutination inhibition and alternate serologic responses following Influenza A(H3N2) virus infection.

Journal: medRxiv : the preprint server for health sciences
Published: May 04, 2026

Hemagglutination Inhibition and Alternate Serologic Responses Following Influenza A(H3N2) Virus Infection.

Hemagglutination Inhibition and Alternate Serologic Responses Following Influenza A(H3N2) Virus Infection.

Journal: Influenza and other respiratory viruses
Published: December 17, 2025

Stunting Increases Influenza Virus Shedding Duration in Preschool/School-Aged Children.

Stunting Increases Influenza Virus Shedding Duration in Preschool/School-Aged Children.

Journal: The Journal of infectious diseases
Published: October 09, 2025

Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A/H3N2 virus.

Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A/H3N2 virus.

Journal: Nature communications
Published: July 29, 2025

1st, 2nd, and 3rd+ SARS-CoV-2 infections: associations of prior infections with protection and severity.

1st, 2nd, and 3rd+ SARS-CoV-2 infections: associations of prior infections with protection and severity.

Journal: medRxiv : the preprint server for health sciences
Published: April 29, 2025

Infection-acquired protection against SARS-CoV-2 infection and clinical severity by number of prior infections.

Infection-acquired protection against SARS-CoV-2 infection and clinical severity by number of prior infections.

Journal: Nature communications
Published: April 16, 2025

Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infections.

Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infections.

Journal: Nature communications
Published: April 08, 2025

Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic overall infections.

Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic overall infections.

Journal: medRxiv : the preprint server for health sciences
Published: February 24, 2025

A comparative analysis of dengue, chikungunya, and Zika in a pediatric cohort over 18 years.

A comparative analysis of dengue, chikungunya, and Zika in a pediatric cohort over 18 years.

Journal: medRxiv : the preprint server for health sciences
Published: January 20, 2025

Comparison of dengue, chikungunya, and Zika among children in Nicaragua across 18 years: a single-centre, prospective cohort study.

Comparison of dengue, chikungunya, and Zika among children in Nicaragua across 18 years: a single-centre, prospective cohort study.

Journal: The Lancet. Child & adolescent health
Published: January 06, 2025

Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua.

Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua.

Journal: PLoS neglected tropical diseases
Published: July 14, 2024

Correction: SARS-CoV-2 and endemic coronaviruses: Comparing symptom presentation and severity of symptomatic illness among Nicaraguan children.

Correction: SARS-CoV-2 and endemic coronaviruses: Comparing symptom presentation and severity of symptomatic illness among Nicaraguan children.

Journal: PLOS global public health
Published: July 03, 2024
Showing 1-12 of 69

Last Updated: 09/26/2026